Isoray To Announce Third Quarter Fiscal 2020 Financial Results on May 12, 2020
RICHLAND, Wash., May 04, 2020 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in […]
Corbus Pharmaceuticals to Report First Quarter Results on May 11, 2020
– Management to host conference call and webcast on Monday, May 11 at 8:30 a.m. ET-NORWOOD, MA, May 04, 2020 […]
Catalyst Pharmaceuticals to Hold First Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 12th, 2020
CORAL GABLES, Fla., May 04, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
Seelos Therapeutics Receives Notice of Allowance for an Additional US Patent for Trehalose (SLS-005)
NEW YORK, May 04, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the […]
Rhode Island Department of Health Leverages SurveyMonkey Enterprise for Agile COVID-19 Tracking System
SAN MATEO, Calif., May 04, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK) today announced that the Rhode Island Department of […]
Nature’s Sunshine Products to Announce First Quarter 2020 Financial Results and to Host Conference Call on Monday, May 11th
LEHI, Utah, May 04, 2020 (GLOBE NEWSWIRE) — Nature’s Sunshine Products (Nasdaq: NATR), a leading natural health and wellness company […]
Krystal Biotech Reports First Quarter 2020 Financial Results and Provides Update on Operational Progress
KB105 interim Phase 1/2 clinical data for treatment of autosomal recessive congenital ichthyosis (ARCI) to be announced at the Society […]
Kelly® Reports First Quarter Earnings
Financial HighlightsQ1 revenue down 8.8%; 2.7% of the decline due to estimated impact of COVID-19 crisisQ1 operating earnings decline on […]
R1 RCM Appoints Rachel Wilson as Executive Vice President and Chief Financial Officer
CHICAGO, May 04, 2020 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management […]
NDA Filing for Potential New ADHD Treatment, KP415, Accepted by FDA; KemPharm Eligible to Receive $5 Million Milestone Payment from Gurnet Point Capital
Corium, GPC’s portfolio company, to lead all commercialization activities for KP415CELEBRATION, Fla., May 04, 2020 (GLOBE NEWSWIRE) — KemPharm, Inc. […]
